SEMINARS IN CANCER BIOLOGY

Seminars in Cancer Biology (ISSN 1044-579X) is a prestigious international academic journal published by Elsevier in the United Kingdom, dedicated to advancing the field of cancer biology through the dissemination of high-quality review articles. Released on a bimonthly basis, the journal is indexed in the Science Citation Index (SCI) and consistently maintains a high impact factor, typically securing a position within the first or second quartile of the Chinese Academy of Sciences journal rankings in the medical and biological sciences categories. The publication focuses on synthesizing current knowledge and evaluating recent progress in critical areas such as tumorigenesis, metastasis, immune therapy, and molecular targeted treatments, thereby providing readers with comprehensive theoretical summaries and critical assessments of emerging research trends. As a non-open access journal with rigorous peer-review standards, it prioritizes the novelty and academic value of its content, though it is specifically designed for review papers rather than original research data. Consequently, the journal serves as a vital resource for researchers, clinicians, and students seeking authoritative overviews of the latest developments in oncology, distinguishing itself from journals that primarily publish primary experimental studies.